Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Rapid Reversal of Psychotic Depression Using Mifepristone

Belanoff, Joseph K., Flores, Benjamin H., Kalezhan, Michelle, Sund, Brenda, Schatzberg, Alan F. · 2001 · Journal of Clinical Psychopharmacology

Abstract

The rationale for treating psychotic major depression with glucocorticoid receptor (GR) antagonists is reviewed. Five patients with psychotic major depression were given 600 mg of mifepristone in a 4-day, double-blind, placebo-controlled crossover study. All the patients completed the protocol and adverse effects were not observed or reported. All of the five patients showed substantial improvements in their Hamilton Rating Scale for Depression scores while they were receiving mifepristone, and four of the five patients showed substantial improvement in their Brief Psychiatric Rating Scale scores. Little, if any, improvement was seen with placebo. These preliminary results suggest that short-term use of GR antagonists may be effective in the treatment of psychotic major depression and that additional study, perhaps using higher doses or more treatment days, seems warranted.

Overview

Integrity signals

Registry

Crossref · 10.1097/00004714-200110000-00009

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Research works printed but not linked: 10

  1. Rothschild, 1985, McLean Hosp J, 2, 68
  2. Chan, 1987, J Clin Psychiatry, 48, 197
  3. Nelson, 1997, Am J Psychiatry, 154, 1497, 10.1176/ajp.154.11.1497 · DOI · Paper page
  4. Proulx-Ferland, 1982, J Steroid Biochem Mol Biol, 17, xvii
  5. Bertagna, 1994, J Clin Endocrinol Metab, 78, 375, 10.1210/jc.78.2.375 · doi:10.1210/jc.78.2.375
  6. Chrousos, 1989, New York: Raven Press, 273-, 84
  7. Murphy, 1993, J Psychiatry Neurosci, 18, 209
  8. de Kloet, 1991, Front Neuroendocrinol, 12, 95
  9. Lamberts, 1991, J Clin Endocrinol Metab, 73, 187, 10.1210/jcem-73-1-187 · DOI
  10. Patel, 2000, J Pysch Res, 0, 1

Cited by

See all 287

Metadata

Authors
Belanoff, J. K., Flores, B. H., Kalezhan, M., Sund, B., & Schatzberg, A. F.
Affiliations
Stanford Medicine (US)
Venue
Journal of Clinical Psychopharmacology
Published
2001-10
Volume
21
Issue
5
Pages
516-521
ISSN
0271-0749 (ISSN-L)
OpenAlex
W1967122944
Cited by
282
References
34
Citations by year
2026: 3 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 8 · 2020: 9 · 2019: 8 · 2018: 8 · 2017: 5 · 2016: 8 · 2015: 11 · 2014: 5 · 2013: 11 · 2012: 14
FWCI
12.76
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Alliance for Research on Schizophrenia and Depression
  • National Institute of Mental Health (MH 47473)
  • NIH Clinical Center
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
mifepristone, psychotic depression, major depressive disorder, glucocorticoid receptor antagonist, rapid antidepressant response, placebo-controlled crossover trial, adverse effects
MeSH terms
Adolescent, Adrenocorticotropic Hormone, Adult, Aged, Major Depressive Disorder, Depressive Disorder, Major, Double-Blind Method, Female, Hormone Antagonists, Humans, Hydrocortisone, Male, Middle Aged, Brief Psychiatric Rating Scale, Psychotic Disorders, Time Factors, Mifepristone, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rapid Reversal of Psychotic Depression Using Mifepristone. https://app.cochat.ai/papers/10.1097/00004714-200110000-00009
The paper
Belanoff, J. K., Flores, B. H., Kalezhan, M., Sund, B., & Schatzberg, A. F. (2001). Rapid Reversal of Psychotic Depression Using Mifepristone. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-200110000-00009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.